Act Fast if a Patient on a “Flozin” Diabetes Med Develops Fournier’s Gangrene

You’ll hear new safety concerns about canagliflozin (Invokana) and other “SGLT2 inhibitors” for type 2 diabetes...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login